Introduction {#s01}
============

Mitochondria are multifunctional cellular organelles present in most eukaryotes. As cellular power plants, mitochondria generate energy in the form of ATP, which is used for diverse cellular activities ([@bib16]). Unlike other cellular organelles with a single membrane, mitochondria are surrounded by outer and inner membranes ([@bib42]). The outer membrane allows ions and small molecules \<6.5 kD to freely diffuse through pore-forming channels; thus, the membrane potential across the outer membrane is negligibly small ([@bib31]; [@bib23]). In contrast, the inner mitochondrial membrane has low permeability, preserving the membrane potential (Δψm) generated by the mitochondrial respiratory chain. Transport of ions through the inner membrane is therefore tightly regulated by ion channels to prevent undesired energy dissipation ([@bib40]).

Δψm is known to be controlled in the narrow range of −136 to −139 mV for optimal ATP synthesis ([@bib19]; [@bib1]). Even subtle (±10%) changes beyond this range critically decrease the ATP synthesis rate and result in significant mitochondrial ROS production ([@bib29]). For this reason, maintenance of membrane integrity and Δψm within the optimal range is essential to ensure a sufficient cellular ATP supply and for intracellular reactive oxygen species (ROS) management. Mitochondrial K^+^ channels in the inner membrane have been proposed to finely regulate Δψm and ROS production ([@bib52]). These channels transport K^+^ ions---the most abundant intracellular monovalent cations---through the inner membrane from the mitochondrial intermembrane space to the negatively charged mitochondrial matrix ([@bib32]). This leads to a subtle depolarization (e.g., ≤2 mV by mitoK~ATP~ channels), which stimulates the respiratory chain to restore Δψm within the optimal range ([@bib30]; [@bib21]; [@bib33]). Although mitochondrial K^+^ channels are primarily involved in this process, nonselective cation channels can also play a role. The most famous nonselective cation channel in the inner membrane is adenine nucleotide translocase (ANT), which switches roles from an ADP/ATP exchanger to a nonselective cation channel (P~K~/P~Cl~ = 4:1) in response to high Ca^2+^ concentration ([@bib4]). Because this channel type has a more powerful depolarizing effect than selective ion channels, opening of nonselective ion channels has been mainly studied in the context of pathological events such as mitochondrial swelling followed by cell death ([@bib20]). For example, ANT is known to be part of the permeability transition pore that facilitates diffusion of ions and small molecules inducing cell death in response to pathological signals. However, flickering of nonselective ion channels in low conductance mode has also been suggested to promote subtle mitochondrial depolarization spikes to maintain mitochondrial homeostasis ([@bib3]).

Although it is clear that mitochondrial nonselective ion channels in the inner membrane have crucial roles in Δψm regulation, few novel mitochondrial ion channels have been identified because of the limitations of conventional homology-based studies. These limitations can be overcome using methods that evaluate local structural similarities ([@bib35]; [@bib48]). For example, it is noteworthy that many viruses encode nonconventional ion channels collectively termed viroporins. These are small hydrophobic proteins with one or two α-helical transmembrane domains (TMDs) that form homooligomeric channels through which protons, cations, and large molecules for viral production are transported ([@bib38]). Interestingly, most viroporins are known to be nonselective cation channels even though they do not exhibit interspecies homology ([@bib12]). Considering that their structural features confer an ion channel function, we posed the following question: do eukaryotes harbor novel nonselective cation channels with viroporin-like structural features that cannot be identified by conventional homology-based methods?

In 2006, the novel mitochondrial protein ROS modulator 1 (Romo1) was identified ([@bib8]). This is a nuclear-encoded small hydrophobic protein composed of 79 amino acids and is expressed ubiquitously in many tissues (brain, heart, skeletal muscle, kidney, pancreas, liver, lung, and placenta; [@bib57]). For a decade, Romo1 has been studied in the context of mitochondrial ROS production ([@bib8], [@bib5]; [@bib37]), cancer cell invasion ([@bib6], [@bib7]; [@bib34]), inflammation ([@bib28]), replicative senescence ([@bib9]), and mitochondrial dynamics ([@bib39]). Although Romo1 is thought to be involved in mitochondrial superoxide production and functions as an essential redox sensor in mitochondrial dynamics, the mechanism by which Romo1 is involved in mitochondrial ROS generation is unknown. In this study, we performed biophysical characterization of Romo1 and demonstrated that it is a unique mitochondrial nonselective cation channel with viroporin-like characteristics.

Results {#s02}
=======

Romo1 is a highly conserved protein with an amphipathic helical TMD {#s03}
-------------------------------------------------------------------

The roles of Romo1 in mitochondria have been studied for a decade, but its biophysical functions have not been elucidated. Prediction of Romo1's biophysical function using homology-based methods is not possible because Romo1 shows no detectable homology to well-known eukaryotic or prokaryotic protein families. Therefore, we attempted to deduce the biophysical functions of Romo1 using a nonhomology-based method that utilizes local structural similarities; this method was proposed as an attractive alternative to homology-based methods for predicting the functions of uncharacterized proteins ([@bib35]; [@bib48]). We found that *Homo sapiens* Romo1 has two TMDs, each consisting of an α helix, that are connected by a basic loop, whereas the N terminus is predicted to be a variable disordered region ([Fig. 1 A](#fig1){ref-type="fig"}). In contrast with TMD1, which contains a hydrophobic α helix, TMD2 contains polar amino acids (K58, T59, Q62, S63, T66, and T69). Interestingly, these amino acids are each separated by three to four amino acids, implying that they are clustered at a single surface in α helix 2, because there are 3.6 amino acids per α-helical turn. We examined the α-helical wheel of the N- and C-terminal α helices and confirmed that the C-terminal α helix in TMD2 forms an amphipathic helix as predicted ([Fig. 1 B](#fig1){ref-type="fig"}). To investigate whether these secondary structural features of Romo1 are conserved throughout eukaryotes, we constructed a phylogenetic tree using the publicly available Romo1 sequences of 460 species (247 animals, 120 fungi, 57 plants, and 36 protists; [Fig. 1 C](#fig1){ref-type="fig"}). Romo1 was sufficiently conserved to distinguish evolutionary relationships among the four kingdoms of Eucarya. Moreover, the amino acid sequences of Romo1 in 82 of 247 animal species were 100% identical with that of *H. sapiens* Romo1, indicating high sequence conservation.

![**Secondary structure analysis of Romo1 in eukaryotes. (A)** Secondary structure prediction of *H. sapiens* Romo1. The Romo1 sequence was described using the WebLogo 3 server. The indicated secondary structures were predicted using JPRED (α-helix), HMMTOP (TMDs), and DISOPRED (disordered region). **(B)** α-Helical wheel of *H. sapiens* Romo1. Illustrations were recreated based on results from the Helical Wheel Projections server. Blue, nonpolar amino acids; red, polar amino acids. **(C)** Phylogenetic relationships of Romo1. A phylogenetic tree was built from 460 Romo1 amino acid sequences using the maximum likelihood method based on the JTT matrix--based model. Evolutionary analyses were performed using MEGA7 software. Blue, fungi; green, plants; red, animals; purple, protists. **(D--F)** Analysis of position-specific polarity conservation. Multiple sequence alignments of nonidentical Romo1 sequences from 104 animal species to determine position-specific polarity conservation (D). Numbers below sequences represent the amino acid position of *H. sapiens* Romo1 based on the results of multiple sequence alignment. Position-specific polarity was calculated as the ratio of conservation of polar amino acids at the indicated position, and bars represent the conservation percentage of polar amino acids. The phylogenetic tree was built with 104 nonidentical sequences using the maximum likelihood method based on the JTT matrix--based model (E). The 104 nonidentical sequences were classified as originating from vertebrates or invertebrates to determine position-specific polarity conservation (F). **(G)** α-Helical wheel of position-specific polarity conservation in animal and fungal species. Numbers around the α-helical wheel represent the amino acid position of *H. sapiens* Romo1.](JCB_201709001_Fig1){#fig1}

We examined whether the position-specific polarity observed in *H. sapiens* Romo1 was conserved across Eucarya. To minimize sequence redundancy, we selected 104 nonidentical sequences from the 247 species of animals. Amino acid positions corresponding with positions 58, 62, and 66 of *H. sapiens* Romo1 showed the same polarity in all animal species investigated, whereas amino acids in positions 54, 55, 59, and 63 did not show consistent polarity across the phylogeny ([Fig. 1 D](#fig1){ref-type="fig"}). We found that the Romo1 sequences of 104 animals could be divided into two groups: vertebrates and invertebrates ([Fig. 1 E](#fig1){ref-type="fig"}). Interestingly, amino acids in positions 54, 55, 59, and 63 showed opposite polarity between vertebrates and invertebrates ([Figs. 1 F](#fig1){ref-type="fig"} and S1). In vertebrates, the polar surface of the amphipathic helix is formed by amino acids at positions 58, 59, 62, 63, 66, and 69; in invertebrates, loss of polarity at positions 59 and 63 appears to be compensated for by acquisition of polar amino acids at positions 54 and 55. This translates into differences in the charge of the polar surface of the amphipathic helix between vertebrates and invertebrates, but amphipathic helical features were still present in both vertebrates and invertebrates ([Fig. 1 G](#fig1){ref-type="fig"}). Similarly, the polar surface of the amphipathic helix was conserved in 120 species of fungi, but the conserved polar surface in fungi was relatively wider than that in animals. These results indicate that Romo1 is a highly conserved protein with amphipathic helical features.

Romo1 forms homooligomers in a membrane environment {#s04}
---------------------------------------------------

To deduce the biophysical function of Romo1 from its secondary structural features, we attempted to find a protein family consisting of small α-helical transmembrane proteins with one amphipathic helical TMD. One family that met this description was class II viroporins, a family of virus-encoded nonselective ion channels. These proteins harbor two TMDs with at least one amphipathic helical TMD, and an amphipathic helical TMD is required for these proteins to form homooligomeric nonselective ion channels. For example, the first TMD of hepatitis C virus (HCV) p7 and the second TMD of picornavirus 2B each consist of an amphipathic α helix that is responsible for ion channel activity ([@bib43]; [@bib49]). These led us to hypothesize that Romo1 is a viroporin-like eukaryotic ion channel. To evaluate this hypothesis, we first examined Romo1 oligomerization, which is a prerequisite for ion channel formation. We lysed isolated mitochondria from HEK293 cells with two detergents: digitonin, which is generally used to preserve protein complex interactions, and octyl-β-[d]{.smallcaps}-glucoside (ODG). We found that Romo1 migrated as three bands in digitonin lysates, whereas it migrated as only one band at ∼30--50 kD in ODG lysates in blue native (BN)/SDS-PAGE ([Fig. 2 A](#fig2){ref-type="fig"}). We added DTT to the ODG lysates to exclude the possibility of disulfide bonds and found that DTT treatment did not affect Romo1 oligomerization ([Fig. 2 B](#fig2){ref-type="fig"}). This indicates that Romo1 oligomerization is not dependent on disulfide bonds.

![**Romo1 oligomerization in mitochondria and artificial membrane environments. (A and B)** Romo1 oligomerization in mitochondria. Isolated mitochondria from HEK293 cells were lysed with 0.5% digitonin (DIG) or ODG. The resultant lysates were analyzed by BN/SDS-PAGE (A). Mitochondrial lysates with 1% ODG were incubated with DTT for 30 min and then analyzed by BN/SDS-PAGE (B). **(C)** Synthesized Romo1 was incubated in 300 mM sucrose and 10 mM Hepes/Tris, pH 7, with 50 mM DHPC or added to MIM-mimicking LUVs (MIM-LUVs) in 300 mM sucrose and 10 mM Hepes/Tris, pH 7, for 2 h at room temperature. The resultant protein products were analyzed by BN/SDS-PAGE. **(D)** MIM-mimicking GUVs (MIM-GUVs) and 8:1:1 (molar ratio) DPhPC/DPhPG/cholesterol (DPhPC-based GUVs) with 0.2% TopFluor-cholesterol were prepared by GUV electroformation. Synthesized TAMRA-labeled Romo1 was added to GUVs for 5 min followed by confocal microscopy analysis. Bar, 10 µm.](JCB_201709001_Fig2){#fig2}

Although we showed that Romo1 forms oligomers in mitochondria, we could not exclude the possibility of detergent-resistant heterooligomers. To clarify whether Romo1 forms homo- or heterooligomers, we chemically synthesized Romo1 and reconstituted it with 1,2-diheptanoyl-*sn*-glycero-3-phosphocholine (DHPC), a detergent widely used for viroporin reconstitution. We found that DHPC-reconstituted Romo1 homooligomerized as tetramers to hexamers (8.2 kD/monomer; [Fig. 2 C](#fig2){ref-type="fig"}); these oligomers were identical to the Romo1 oligomers detected in mitochondria isolated from HEK293 cells ([Fig. 2 A](#fig2){ref-type="fig"}). We also reconstituted Romo1 in large unilamellar vesicles (LUVs) with a previously reported rat liver mitochondrial inner membrane (MIM) composition ([@bib11]) to mimic the membrane environment. We confirmed that Romo1 forms homooligomers in a membrane environment similar to DHPC-reconstituted Romo1 ([Fig. 2 C](#fig2){ref-type="fig"}). To determine whether Romo1 targets liposomes, we visualized Romo1 targeting using 5-carboxy-tetramethylrhodamine (TAMRA)-labeled Romo1 and giant unilamellar vesicles (GUVs). As expected, TAMRA-Romo1 was clearly targeted to MIM-GUVs and 1,2-diphytanoyl-*sn*-glycero-3-phosphocholine (DPhPC)-based GUVs ([Fig. 2 D](#fig2){ref-type="fig"}). We also confirmed the oligomerization of MIM-GUV--reconstituted TAMRA-Romo1 (Fig. S2 A). These results indicate that Romo1 forms stable homooligomers of 30--50 kD in mitochondria and an artificial membrane environment.

Romo1 induces membrane permeabilization {#s05}
---------------------------------------

The ability of viroporins to induce membrane permeabilization has been studied extensively ([@bib38]); we therefore examined whether Romo1 possesses viroporin-like pore-forming activity in a membrane environment. To evaluate the pore-forming activity of Romo1, we used a liposome permeabilization assay frequently used in viroporin research ([@bib38]). We generated MIM-LUVs filled with carboxyfluorescein (CF), a fluorescent dye quenched at high concentrations, and found that Romo1 induced liposome permeabilization in a concentration- and time-dependent manner ([Fig. 3, A and B](#fig3){ref-type="fig"}). Moreover, the activity of Romo1 was more potent than that of the well-known pore-forming antimicrobial peptide alamethicin. Because our analysis implied that TMD2 forms a membrane-active pore-forming domain, we synthesized the 1--43 and 44--79 regions of Romo1 ([Fig. 3 C](#fig3){ref-type="fig"}) and found that 44--79 induced liposome permeabilization, whereas 1--43 did not ([Fig. 3 D](#fig3){ref-type="fig"}). We also synthesized the sequential deletion mutants from the C terminus of 44--79 (44--75, 44--70, and 44--65), but its sequential deletion mutants did not induce liposome permeabilization ([Fig. 3 E](#fig3){ref-type="fig"}).

![**Romo1-induced membrane permeabilization. (A--E)** Romo1-induced liposome permeabilization. CF-LUVs were incubated with the indicated concentrations of Romo1, and liposome permeabilization was monitored by a spectrophotometric assay (A). **(B)** CF release was quantified at 10 min after Romo1 treatment. **(C)** Illustration of deletion mutants of Romo1. **(D and E)** CF-LUVs were incubated with Romo1 or the indicated deletion mutants (1 µM) for 10 min, after which liposome permeabilization was analyzed. Alamethicin (Ala.) was used as a positive control. **(F--K)** Romo1-induced mitochondrial depolarization. **(F)** The purity of isolated mouse liver mitochondria was examined by flow cytometry using the mitochondrial-specific marker MitoTracker green FM. **(G and H)** Mitochondrial targeting of Romo1 was analyzed by flow cytometry with 0.2 µM TAMRA-Romo1 (G) and confirmed by confocal microscopy (H). Bar, 10 µm. **(I and J)** Isolated liver mitochondria were treated with the indicated concentrations of Romo1 for 5 min and then stained with the Δψm indicator JC-1, after which they were analyzed by flow cytometry (I) and spectrophotometric assay (J). **(K)** Romo1 or its deletion mutants (1 µM) were added to isolated liver mitochondria for 5 min followed by staining with JC-1, after which Δψm was quantified by spectrophotometric assay. Carbonyl cyanide m-chlorophenyl hydrazine (CCCP) was used as a positive control. **(L--N)** CF-LUVs were incubated with the indicated deletion or point mutants of Romo1 (1 µM) for 10 min, and liposome permeabilization was quantified by a spectrophotometric assay. Data represent means ± SD of three independent experiments. \*\*\*, P ≤ 0.001 by two-way ANOVA. Cont., control.](JCB_201709001_Fig3){#fig3}

We next investigated the effects of Romo1-induced membrane permeabilization on mitochondria. Because MIM permeabilization can be assessed by measuring the decrease in Δψm, we examined whether Romo1 depolarizes mitochondria. Although Romo1 expression has been shown to decrease Δψm in cells ([@bib9]; [@bib28]), it is difficult to determine whether this mitochondrial depolarization is caused by the direct effect of Romo1 on pore-forming activity or an indirect effect. We therefore designed an experimental workflow for directly targeting synthesized Romo1 to isolated liver mitochondria to minimize the effects of cellular factors. We first confirmed the purity (\>90%) of isolated liver mitochondria by flow cytometry using MitoTracker green FM ([Fig. 3 F](#fig3){ref-type="fig"}). Next, we evaluated the targeting of Romo1 by adding TAMRA-Romo1 to isolated liver mitochondria and found that Romo1 was efficiently targeted to the isolated mitochondria within 5 min ([Fig. 3, G and H](#fig3){ref-type="fig"}). To evaluate Romo1-induced mitochondrial depolarization, Romo1-treated mitochondria were stained with the Δψm indicator JC-1. We found that Romo1 induced mitochondrial depolarization in a concentration-dependent manner ([Fig. 3, I and J](#fig3){ref-type="fig"}). The deletion mutant 44--79 also induced mitochondrial depolarization, but the sequential deletion mutants 44--75, 44--70, and 44--65 had negligible effects ([Figs. 3 K](#fig3){ref-type="fig"} and S3). Because it is still unclear whether the length of TMD2 or C-terminal amino acids is essential for the formation of pores, we synthesized additional deletion mutants (44--78, 44--77, and 44--76) based on 44--79. Surprisingly, deletion of C79 affected the Romo1 activity significantly ([Fig. 3 L](#fig3){ref-type="fig"}). Moreover, the C79A mutant showed decreased activity compared with 44--79 ([Fig. 3 M](#fig3){ref-type="fig"}). These results are consistent with results of [@bib39] showing that C15 and C79 are essential for redox sensor function of Romo1 in mitochondrial dynamics, and C-terminally tagged Romo1 showed a dominant-negative effect on mitochondrial fusion. We also examined the F67A + F70A mutant (FFAA), which has been demonstrated as a dominant-negative mutant ([@bib39]). We found that it forms a stable oligomer in mitochondria regardless of DTT treatment (Fig. S2 B). We synthesized the FFAA mutant (based on 44--79) to examine whether it affects Romo1 channel activity. Surprisingly, the FFAA mutant showed no effect on liposome permeabilization ([Fig. 3 N](#fig3){ref-type="fig"}). Therefore, the dominant-negative effect of Romo1 FFAA mutant on mitochondrial dynamics may be caused by loss of channel activity. Collectively, these results indicate that the homooligomeric form of Romo1 can induce membrane permeabilization and that the C-terminal amphipathic helix TMD2 is essential for pore-forming activity.

Romo1 shows ion channel activities in bilayer patch clamp experiments, and its activity is inhibited by a viroporin inhibitor {#s06}
-----------------------------------------------------------------------------------------------------------------------------

To determine whether Romo1 functions as an ion channel, we performed planar bilayer patch clamp assays using synthesized Romo1. Because Romo1 readily aggregated when salts were used in the targeting buffer, we designed a novel targeting method applicable to our bilayer patch clamp system to maximize targeting efficiency ([Fig. 4 A](#fig4){ref-type="fig"}). Because 1 M sorbitol has a greater density than the recording buffer used (150 mM KCl and Hepes/Tris, pH 7), we speculated that Romo1 diluted with sorbitol solution could be overlaid on the preformed planar bilayer, thus effectively targeting Romo1 to the bilayer. To ensure that the method we designed functioned as planned, we added GUVs to form a planar bilayer on a glass chamber filled with 150 mM KCl and 10 mM Hepes/Tris, pH 7, and then overlaid the Romo1-containing sorbitol solution. As expected, Romo1 (red) exhibited satisfactory targeting to the preformed bilayer (green) within 5 min ([Fig. 4 B](#fig4){ref-type="fig"}). We applied this method to a planar bilayer patch clamp system. A symmetrical buffer containing 150 mM KCl and 10 mM Hepes/Tris, pH 7, was used as both the external and internal buffer ([Fig. 4 C](#fig4){ref-type="fig"}). After Romo1-containing sorbitol solution was added to the preformed bilayer, the ion channel activity of Romo1 was monitored after application of −120 mV. We found that Romo1 showed single-channel activity ([Fig. 4 D](#fig4){ref-type="fig"}) with low conductance (21 pS; [Fig. 4 E](#fig4){ref-type="fig"}). Because Romo1 currents increased continuously throughout Romo1 targeting, the single-channel current was observed for only a limited time and then changed to viroporin-like macroscopic currents ([Fig. 4 F](#fig4){ref-type="fig"}). The macroscopic currents of Romo1 showed a double-rectification current--voltage (I--V) relationship ([Fig. 4 G](#fig4){ref-type="fig"}). We also tested the 44--79 region that was predicted to be a pore-forming domain; as expected, this region showed ion channel activity with low conductance (17 pS; [Fig. 4 H](#fig4){ref-type="fig"}).

![**Measurement of the ion channel activity of Romo1. (A)** Illustration of planar bilayer formation and Romo1 targeting. **(B)** Romo1 targeting to the planar bilayer. GUVs (8:1:1 DPhPC/DPhPG/cholesterol molar ratio) were used to form a planar bilayer in a glass chamber filled with 150 mM KCl and 10 mM Hepes/Tris, pH 7. TAMRA-Romo1 (in 1 M sorbitol) was overlaid onto the planar bilayer for 5 min, after which the bilayer was washed with 150 mM KCl and 10 mM Hepes/Tris, pH 7. Images were captured using a fluorescence microscope. Bar, 40 µm. **(C)** Illustration of the NPC-1 chip used in the Port-a-Patch system. External and internal buffers were the same, i.e., 150 mM KCl and 10 mM Hepes/Tris, pH 7. Gray, NPC-1 chip; green, planar bilayer, pale blue; internal and external buffers. **(D--F)** Bilayer patch clamp assay of Romo1. Romo1 (in 1 M sorbitol) was added to a preformed planar bilayer, and a voltage of −120 mV was applied. Activities were then monitored. D shows the single channel current at −120 mV and E shows histogram of single channel conductance of Romo1. **(F)** Macroscopic currents using a step protocol from −150 to 150 mV were recorded. **(G)** I--V relationship of macroscopic currents. Currents from a ramp protocol from −150 to 150 mV (2-s duration) were averaged from five sweeps and plotted on the I--V curve. **(H)** Ion channel activity of the 44--79 region of Romo1. Control data were acquired before treatment with 44--79.](JCB_201709001_Fig4){#fig4}

Because we suggested that Romo1 is a viroporin-like ion channel, we tested viroporin inhibitors on Romo1 channel activity. Interestingly, channel activity of Romo1 was inhibited by hexamethylene amiloride (HMA) but not by amantadine, rimantadine, or *N*-nonyldeoxynojirimycin (Fig. S4 A). Because knockdown of Romo1 expression was shown to increase the Δψm ([@bib28]), we applied these inhibitors to HEK293 cells and found that HMA increased the Δψm, but no other viroporin inhibitor had this effect (Fig. S4, B and C). Next, we examined the inhibitory effects of HMA on the previously reported Romo1-induced mitochondrial depolarization ([@bib28]). We found that 1 µM HMA was sufficient to inhibit Romo1-induced mitochondrial depolarization (Fig. S4 D) and that Flag-Romo1 expression was not altered by HMA treatment (Fig. S4 E). Because Romo1-induced mitochondrial depolarization was shown to be directly linked with TNF-α/cycloheximide (CHX)--induced mitochondrial depolarization ([@bib28]), we tested the effect of HMA on TNF-α/CHX--induced mitochondrial depolarization. As expected, only HMA blocked TNF-α/CHX--induced mitochondrial depolarization (Fig. S4 F). These results demonstrate that Romo1 functions as an viroporin-like ion channel in artificial bilayer and that TMD2 is sufficient to induce ion channel activity.

Romo1 is a nonselective monovalent cation channel {#s07}
-------------------------------------------------

We hypothesized that Romo1 is a nonselective cation channel like class II viroporins. To examine the selectivity of the channel for K^+^ versus Cl^−^ ions, the external buffer was exchanged to a buffer containing 1.5 M KCl and 10 mM Hepes/Tris, pH 7. The reversal potential was measured to be 42.3 ± 1.4 mV (means ± SD), indicating that Romo1 exhibits ∼10 times more selectivity for K^+^ over Cl^−^ ions ([Fig. 5 A](#fig5){ref-type="fig"}). Because Romo1 lacks a conserved potassium filter such as the TVGYG sequence, we assumed that Romo1 would not display specific potassium ion selectivity. As expected, Romo1 did not exhibit specific selectivity among monovalent cations ([Fig. 5 A](#fig5){ref-type="fig"}) but did show Stokes radius-dependent cation selectivity ([Fig. 5 B](#fig5){ref-type="fig"}), implying that cations diffuse through the channel without dehydration. Interestingly, when a buffer containing 100 mM CaCl~2~ and 10 mM Hepes/Tris, pH 7, was used to measure the ion selectivity of monovalent over divalent cations, CaCl~2~ inhibited the Romo1 current, and no reversal potential was measured ([Fig. 5 C](#fig5){ref-type="fig"}). This phenomenon was also observed in liposome permeabilization assays with CaCl~2~ or MgCl~2~ ([Fig. 5 D](#fig5){ref-type="fig"}). We also examined the effect of Gd^3+^, a nonselective cation channel blocker. As expected, Romo1-induced liposome permeabilization was efficiently blocked by Gd^3+^ ions ([Fig. 5 E](#fig5){ref-type="fig"}). These results indicate that Romo1 is a nonselective monovalent cation channel.

![**Determination of ion selectivity of Romo1. (A and B)** Ion selectivity of Romo1. The external buffer was changed to 1.5 M KCl and 10 mM Hepes/Tris, pH 7, to determine selectivity for K^+^ versus Cl^−^. To determine selectivity for K^+^ versus cations, the external buffer was changed to 150 mM XCl and 10 mM Hepes/Tris, pH 7, and the reversal potential was calculated where X represents the indicated cation. Reversal potential was corrected by the liquid junction potential. **(C and D)** Effects of divalent cation on the channel activity of Romo1. **(C)** The external buffer was changed to 100 mM CaCl~2~, and the current was recorded using a step protocol from −150 to 150 mV. **(D)** CF-LUVs were incubated with the indicated concentrations of CaCl~2~ or MgCl~2~, and Romo1 (50 nM) was added for 10 min, after which liposome permeabilization was analyzed. **(E)** Effects of GdCl~3~ on Romo1-induced liposome permeabilization. CF-LUVs were incubated with the indicated concentration of GdCl~3~, and Romo1 (50 nM) was added for 10 min, after which liposome permeabilization was analyzed. Data represent means ± SD of three independent experiments. \*\*\*, P ≤ 0.001 by two-way ANOVA.](JCB_201709001_Fig5){#fig5}

Romo1 activity is inhibited by Fe^2+^ ions {#s08}
------------------------------------------

We showed that Romo1 induces membrane permeabilization ([Fig. 3](#fig3){ref-type="fig"}) and functions as a nonselective monovalent cation channel ([Fig. 5](#fig5){ref-type="fig"}). However, Romo1 appears to open without any activators under our artificial experimental conditions, i.e., liposome permeabilization and bilayer patch clamp assays. Because constitutively activated Romo1 in mitochondria could induce the undesired depolarization of Δψm, we expected that certain cellular factors would keep Romo1 in the closed state. Because Romo1 has been studied mainly in the context of mitochondrial ROS production, we first examined the effect of H~2~O~2~---the most important ROS in intracellular signaling---on Romo1-induced liposome permeabilization, but it showed no inhibitory effect ([Fig. 6 A](#fig6){ref-type="fig"}). We next explored factors known to be involved in mitochondrial ROS metabolism. Transition metal ions (Cu^2+^, Zn^2+^, and Fe^2+^) are essential for mitochondrial function and are closely related to intracellular ROS management ([@bib47]); we therefore tested whether they inhibited Romo1 activity. Surprisingly, we found that Fe^2+^ specifically inhibited Romo1-induced liposome permeabilization, whereas Cu^2+^ and Zn^2+^ did not ([Fig. 6 B](#fig6){ref-type="fig"}).

![**Inhibitory effect of Fe^2+^ ions on Romo1 activity. (A)** Inhibitory effect of H~2~O~2~ on Romo1-induced liposome permeabilization. CF-LUVs were incubated with the indicated concentrations of H~2~O~2~, and Romo1 (50 nM) was added for 10 min. **(B--D)** Determination of the inhibitory effects of transition metal ions on Romo1 activity. CF-LUVs were incubated with the indicated ions (10 µM), and Romo1 (50 nM) was added for 10 min. Alamethicin (Ala.; 0.5 µM) was used as a negative control (B). The IC~50~ of Fe^2+^ was quantified by liposome permeabilization assay (C). CF-LUVs were incubated with the indicated ions (1 µM), and Romo1 (50 nM) was added for 10 min (D). Data represent means ± SD of three independent experiments. \*\*\*, P ≤ 0.001 by two-way ANOVA. Cont., control; D.W., distilled water.](JCB_201709001_Fig6){#fig6}

It is noteworthy that iron is indispensable for mitochondrial enzymatic reactions and thus crucial for mitochondrial respiration. Iron ions can readily cycle between oxidized and reduced states in response to changes in the intracellular ROS environment. Because redox-active cytosolic free iron ions (also known as the cytosolic labile iron pool) are highly toxic in the cellular environment, most intracellular iron is stored in the nontoxic form of ferritin. Therefore, cytosolic free iron (0.2--1.5 µM, variable according to cell type) accounts for \<5% of the total iron concentration and mainly comprises Fe^2+^ because of the reductive nature of the intracellular environment ([@bib26]; [@bib54]). We therefore investigated whether Romo1 function is inhibited by physiological concentrations of Fe^2+^. The half-maximal inhibition (IC~50~) value of Fe^2+^ was determined to be 0.4 µM ([Fig. 6 C](#fig6){ref-type="fig"}). Moreover, Romo1-induced liposome permeabilization was not inhibited by Fe^3+^, an oxidized form of Fe^2+^ ([Fig. 6 D](#fig6){ref-type="fig"}). Considering that the intracellular free iron concentration ranges from 0.2--1.5 µM, our results indicate that Romo1 could be regulated in response to fluctuation in free iron concentration and redox state of iron.

Computational modeling of Romo1 reveals a hexameric ion channel model {#s09}
---------------------------------------------------------------------

In this study, we showed that Romo1 is a small α-helical nonselective cation channel with characteristics of class II viroporins. These structural and functional features, which differ from those of currently identified eukaryotic ion channels, motivated us to determine the tertiary structure of the Romo1 oligomer. Because Romo1 is difficult to characterize by x-ray crystallography or nuclear magnetic resonance imaging because of its small size and hydrophobic nature, we designed an experimental data--guided structure prediction workflow extending from sequence to oligomer models by applying structural bioinformatics ([Fig. 7 A](#fig7){ref-type="fig"}). As the first step, we deleted the flexible M1--S14 region predicted to be a disordered domain ([Fig. 1 A](#fig1){ref-type="fig"}) because it hindered oligomeric structural prediction. The C15--C79 region was used for tertiary structure prediction using Robetta ([@bib27]) and LOMETS ([@bib56]), leading to the prediction of 15 monomer models. We selected monomer models based on the α-helical structure of Romo1 predicted in [Fig. 1 A](#fig1){ref-type="fig"} and the reported membrane topology of Romo1 (the N and C termini are in the same direction; [@bib24]). This led to the selection of five potential monomer models from among the 15 monomer models ([Fig. 7 B](#fig7){ref-type="fig"}). Next, we docked the Romo1 monomers from tetramers to hexamers using M-ZDOCK ([@bib45]). This oligomer choice was in the range of predicted oligomers shown in [Fig. 2](#fig2){ref-type="fig"} and generated 150 oligomer models. Because we already demonstrated that the TMD2 of Romo1 possesses pore-forming activity ([Fig. 3 D](#fig3){ref-type="fig"}), we selected TMD2-based pore-forming models (47 oligomers) and excluded highly tilted or TMD1-based pore-forming models. Among the 47 oligomer models, we selected 11 top oligomer models (3 tetramers, 4 pentamers, and 4 hexamers), each of which showed a different structural shape based on the M-ZDOCK criteria with visual inspection. Next, we performed structure refinement using GalaxyRefine-Complex ([@bib22]) to improve the structural quality of the 11 oligomer models. As a last step, we evaluated the 11 oligomer models that had pores that were sufficiently large to allow passage of hydrated Li^+^ ions, consistent with our bilayer patch clamp assay results ([Fig. 5 A](#fig5){ref-type="fig"}), using PoreWalker ([@bib44]) and Chexvis (Fig. S5; [@bib36]). Finally, one hexamer model remained ([Fig. 7 C](#fig7){ref-type="fig"}). In this hexamer model, the polar surface of the amphipathic helix faced the inside of the pore ([Fig. 7 D](#fig7){ref-type="fig"}). The bottleneck diameter of the Romo1 channel was predicted to be 4.79 Å in PoreWalker and 4.94 Å in Chexvis. K58, T59, Q62, T66, and T69 were predicted to be pore-lining residues by both PoreWalker and Chexvis ([Fig. 7 E](#fig7){ref-type="fig"}). These amino acids were those already predicted to be polar surface residues of the amphipathic helix, as shown in [Fig. 1 B](#fig1){ref-type="fig"}.

![**Experimental data--guided Romo1 structural modeling. (A)** Computational modeling workflow designed to predict Romo1 structure. **(B--E)** The Robetta and LOMETS servers predicted 15 monomers from the *H. sapiens* Romo1 sequence, of which five were selected (B). After application of the selection criteria, 1 hexamer remained (C and D). Pore-lining residues that were predicted in both PoreWalker and Chexvis server were visualized (E). **(F--H)** Romo1 point mutants from 44--79 were synthesized based on the predicted hexamer structure. The following mutants were synthesized: E51A, K58A, Q62A, and R78A. Mitochondrial depolarization (F) and liposome permeabilization (G and H) induced by the four Romo1 point mutants (1 µM) were quantified by spectrophotometric assay. Data represent means ± SD of three independent experiments. \*\*\*, P ≤ 0.001 by two-way ANOVA. Cont., control.](JCB_201709001_Fig7){#fig7}

Interestingly, the positively charged amino acid K58 is located inside the pore ([Fig. 7 E](#fig7){ref-type="fig"}) in this model. This finding is somewhat counterintuitive because a positively charged lysine conflicts with the cation selectivity of Romo1. However, we found a similar example in a recent viroporin study: the nonselective cation channel HCV p7 harbors a positively charged amino acid, arginine (R35), at the pore entrance ([@bib41]). This residue was proposed to bind to anions and obstruct their diffusion while allowing diffusion of cations through the pore. We investigated whether this concept applied to Romo1. We synthesized a K58A mutant in addition to mutants of two charged residues: the pore-lining residue E51 and the residue R78 (outside the pore) in the 44--79 region. Surprisingly, the K58A mutant showed decreased induction of mitochondrial depolarization ([Fig. 7 F](#fig7){ref-type="fig"}) and liposome permeabilization ([Fig. 7 G](#fig7){ref-type="fig"}), whereas these effects were not observed in the E51A or R78A mutant; rather, the E51A mutant showed increased activity. To examine whether the K58A mutant actually forms an oligomer, we overexpressed the Flag--Romo1-K58A in HEK293 cells and found that it forms a stable oligomer (Fig. S2 C). We also predicted that the bottleneck of the Romo1 channel is located near the Q62 region ([Fig. 7 E](#fig7){ref-type="fig"}). We expected that a widened bottleneck would increase the activity compared with that of 44--79. Therefore, we synthesized the Q62A mutant based on 44--79 and found that it showed increased activity compared with 44--79 ([Fig. 7 H](#fig7){ref-type="fig"}). Collectively, our results imply that Romo1 can function as a hexameric nonselective cation channel in a manner analogous to viroporins.

Discussion {#s10}
==========

Romo1 was first identified in 2006 and has been reported to have a role in mitochondrial ROS production and related signaling pathways ([@bib8]). Subsequent experiments demonstrated that Romo1 induces mitochondrial ROS production in response to various cellular stresses, e.g., inflammation, senescence, and serum deprivation. In the case of inflammation, for example, internalized TNF-α complex II binds to Romo1, inducing mitochondrial depolarization within 15 min ([@bib28]). Notably, TNF-α--mediated mitochondrial depolarization and ROS production were efficiently inhibited by knockdown of Romo1 expression. Considering the channel activity that we demonstrated, Romo1 is likely to be closed to minimize undesired energy dissipation and specifically activated in certain stress environments. This assumption is also consistent with the expected function of a mitochondrial cation channel: it should be tightly regulated for optimal mitochondrial respiration. For example, mitoK~ATP~ channels are generally accepted to be mainly closed at high concentrations of intracellular ATP, but they can be activated in response to a decrease in ATP/ADP ratio ([@bib32]). In this study, we found that the channel activity of Romo1 was inhibited by free Fe^2+^ ions and that the IC~50~ for Fe^2+^ (0.4 µM) was within the cytosolic free iron concentration range (0.2--1.5 µM; [Fig. 6](#fig6){ref-type="fig"}). Considering this, the channel activity of Romo1 could be regulated by the cytosolic free iron concentration, and channel activity is likely maintained at the lowest acceptable level by cellular factors such as Fe^2+^ to minimize undesired loss of Δψm.

This raises the questions of how and why Romo1 regulates mitochondrial ROS production. Romo1-induced mitochondrial superoxide production originates from complex III of the respiratory chain ([@bib9]). Interestingly, knockdown of Romo1 expression has been reported to reduce ([@bib39]) or increase ([@bib9]) mitochondrial superoxide production depending on experimental conditions. Similar to these studies, even using the same isolated mitochondria models, mitochondrial K^+^ channels have been reported to increase or decrease ROS production ([@bib52]). These findings can be explained in the context of the fine tuning of Δψm. Because Δψm is tightly regulated in a narrow range for optimal respiration, a value even 10% out of this range could increase the production of ROS significantly. Romo1 and mitochondrial cation channel--induced subtle depolarization could fit the optimal range or lower than this range depending on experimental conditions. For example, if Δψm is slightly higher than the optimal range, activation of these channels could fine tune the Δψm, in turn reducing ROS production. In contrast, if Δψm is already in the optimal range, further depolarization could induce ROS production. Collectively, these results suggest that Romo1 fine tunes Δψm to regulate mitochondrial ROS production in response to cellular factors such as Fe^2+^. In future studies, we intend to focus on potential correlations between Romo1-induced ROS production and free intracellular iron fluctuations including variations in the redox state of irons.

Romo1 might interact with other mitochondrial protein complexes to maintain their optimal activities. We observed homooligomers with two additional bands in digitonin-lysed mitochondria. These bands could represent Romo1 homooligomers, but this might be a result of interaction with other protein complexes ([Fig. 2 A](#fig2){ref-type="fig"}). Indeed, Romo1 has been reported to interact with protein complexes involved in mitochondrial dynamics and protein transport. In the context of mitochondrial dynamics, Romo1 has been shown to bind to OPA1 and the MIM organizing system (MINOS) complex, both of which are required to form cristae junctions for maximum respiration potential ([@bib39]). Moreover, knockdown of Romo1 was shown to decrease the number of cristae junctions and the mitochondrial fusion rate. This can be explained by plasma membrane--resident viroporins, which have been shown to decrease the electrostatic repulsion of contact membranes for viral budding ([@bib38]). Binding of Romo1 to the MINOS complex transiently decreases the local membrane potential between the inner membranes to reduce electrostatic repulsion, after which membrane contact is formed and cristae junctions are created. This hypothesis can also be applied to the role of Romo1 in mitochondrial protein transport. Mgr2 (Romo1 in *Saccharomyces cerevisiae*) was shown to bind to the translocase of the inner membrane 23 (TIM23) complex, which is essential for protein translocation into the MIM and matrix ([@bib18]). Interestingly, TIM and translocase of the outer membrane (TOM) complexes did not interact at elevated temperatures in Romo1-knockout *S. cerevisiae*. Multiple studies have shown that the TIM and TOM complexes are coupled at contact sites of the two membranes ([@bib50]; [@bib25]; [@bib14]); therefore, the distance between the inner and outer membranes must be sufficiently small to enable contact between the TIM and TOM complexes. One possibility is that Romo1 decreases local electrostatic repulsion below the threshold to maintain contact between the TIM and TOM complexes as we suggested above for cristae junction formation. However, there are not any currently available techniques by which local membrane potential decreases in mitochondria can be detected; such techniques would need to be developed to demonstrate the function of Romo1 in reducing electrostatic repulsion between membranes.

It is noteworthy that viroporins possess an unusual feature referred to as channel-pore dualism ([@bib15]). This phenomenon indicates that viroporins can function as an ion channel or large pore depending on the experimental conditions. For example, HCV p7 conducts H^+^, Na^+^, K^+^, and Ca^2+^ ions and even allows passage of large molecules like CF and 10-kD dextran ([@bib46]; [@bib51]). Interestingly, HCV p7 has been shown to adopt two different structures for proton versus fluorescent dye release, which provides some support for the channel-pore dualism phenomenon ([@bib17]). Because Romo1 also induces release of CF from liposomes ([Fig. 3 A](#fig3){ref-type="fig"}), it is also possible that Romo1 adopts other structures based on the channel-pore dualism theory.

In conclusion, we described a novel mitochondrial nonselective cation channel with viroporin-like characteristics. To our knowledge, this is the first demonstration of a viroporin-like nonselective cation channel in eukaryotes. We provided key evidence of the core function of Romo1 in the context of mitochondrial ROS production and also suggested that some membrane proteins that were not previously considered to be ion channels could potentially be classified as viroporin-like nonselective cation channels. We expect that identification of additional viroporin-like nonselective cation channels will shed light on ion channel function in eukaryotes.

Materials and methods {#s11}
=====================

Chemicals {#s12}
---------

Egg [l]{.smallcaps}-α-phosphatidylcholine (PC), egg [l]{.smallcaps}-α-phosphatidylethanolamine (PE), liver [l]{.smallcaps}-α-phosphatidylinositol (PI), brain [l]{.smallcaps}-α-phosphatidylserine (PS), bovine heart cardiolipin (CL), DPhPC, 1,2-diphytanoyl-*sn*-glycero-3-phospho-(1\'-*rac*-glycerol) (DPhPG), and TopFluor-cholesterol were purchased from Avanti Polar Lipids. All other chemicals were purchased from Sigma-Aldrich. Anti-Romo1 antibody (TA505580) was purchased from Origene. *H. sapiens* Romo1 (MPVAVGPYGQ^10^ SQPSCFDRVK^20^ MGFVMGCAVG^30^ MAAGALFGTF^40^ SCLRIGMRGR^50^ ELMGGIGKTM^60^ MQSGGTFGTF^70^ MAIGMGIRC^79^) was chemically synthesized with or without TAMRA by GL Biochem and purified by HPLC.

Liposome permeabilization assay {#s13}
-------------------------------

For LUV preparation, 100 µl of a MIM-mimic lipid mixture (egg PC/egg PE/liver PI/brain PS/heart CL = 40:34:5:3:18 \[weight ratio\] dissolved in 4:1 chloroform/methanol \[10 mg/ml\]) was dried under a stream of nitrogen and rehydrated with 500 µl of 50 mM CF, 100 mM sucrose, and 5 mM Hepes/KOH, pH 8. Multilamellar liposomal suspensions were extruded through a 0.1-µm polycarbonate membrane using a Mini Extruder (Avanti Polar Lipids) and purified on a PD-10 desalting column (GE Healthcare). The standard external buffer was 150 mM KCl and 10 mM Hepes/Tris, pH 7. The osmotic pressures of all experimental buffers were adjusted to ∼300 mOsm with sucrose using a VAPRO osmometer (Wescor Inc.). For CF-LUVs incubated with 10 mM CaCl~2~ or MgCl~2~, 135 mM KCl were used to adjust the osmotic pressure. LUVs treated with 90% trifluoroethanol (TFE) were used as a control. The final TFE concentration was restricted to 0.9%, a percentage at which no significant CF release was observed. CF leakage was analyzed at λ 488-nm excitation and 517-nm emission using a SpectraMax 384 microplate reader (Molecular Devices) and calculated using the formula CF leakage (%) = 100 × (*F* − *F*~0~)/(*F*~max~ − *F*~0~), where *F* is the measured fluorescence intensity, *F*~0~ is the fluorescence intensity of intact LUVs, and *F*~max~ is the fluorescence intensity of LUVs treated with 0.1% Triton X-100.

Romo1 oligomerization assay {#s14}
---------------------------

Mitochondria were isolated from HEK293 cells using a mitochondrial isolation kit (Thermo Fisher Scientific). To assess Romo1 oligomerization, mitochondria isolated from HEK293 cells were lysed with 0.5% digitonin or 1% ODG for 1 h on ice. Lysates were analyzed by BN-PAGE using NativePAGE Novex 4--16% Bis-Tris gels (Invitrogen). A BN-PAGE gel strip was used for secondary SDS-PAGE. For the homooligomerization assay, synthesized Romo1 was incubated with 50 mM DHPC, 300 mM sucrose, and 10 mM Hepes/Tris, pH 7, or added to MIM-LUVs in 300 mM sucrose and 10 mM Hepes/Tris, pH 7, for 2 h at room temperature. For MIM-LUV--reconstituted Romo1, samples were lysed with 1% ODG before BN/SDS-PAGE.

GUV preparation {#s15}
---------------

An 8:1:1 DPhPC/DPhPG/cholesterol (molar ratio) mixture dissolved in chloroform (5 mM) or a MIM-mimic lipid mixture was used to produce GUVs using a Vesicle Prep Pro (Nanion Technologies). GUVs were electroformed following the manufacturer's instructions. In brief, the lipid mixture was dried on indium tin oxide--coated glass, and the chamber was filled with 300 mM sucrose. GUVs were produced by application of 3 V peak-to-peak and 5 Hz for 2 h at 36°C. For confocal microscopy, each cover glass was spin coated with 3% polyvinyl alcohol to ensure GUV stability. Data were acquired using an LSM 700 microscope (ZEISS).

Bilayer patch clamp assay {#s16}
-------------------------

Bilayer patch clamp assays were performed with a Port-a-Patch system (Nanion Technologies) using a 3--5-Mohm NPC-1 chip and amplified with an EPC-10 amplifier (HEKA Electronics). The same buffer was used in the external and internal chambers (150 mM KCl and 10 mM Hepes/Tris, pH 7). DPhPC-based GUVs were dropped onto the chip, and a pressure of −15 to −25 mbar was applied. After forming the correct seal over 5 Gohm, the bilayer was tested using a −150 to 150 mV ramp protocol to ensure bilayer stability. The baseline value was subtracted before Romo1 targeting to generate the I--V curve. For Romo1 targeting, Romo1 (in 90% TFE) was diluted with 1 M sorbitol and rapidly overlaid on the chip. Next, −120 mV was applied. The external buffer was quickly exchanged with the indicated buffer after the Romo1 signal was detected. For ion-selectivity calculations, the reversal potential of the zero mean current was recorded and corrected by the liquid junction potential calculated using JPCalcWin software ([@bib2]). The Goldman-Hodgkin-Katz equation was used to obtain P~X~/P~K~ (Eq. 1) and P~K~/P~Cl~ (Eq. 2). RT/zF was 25.6 at 25°C. All data were Gaussian low pass--filtered at 1 kHz.

E~rev~ = (RT/zF)ln(\[X\]~ex~P~X~/\[K\]~in~P~K~) (Eq. 1)

E~rev~= (RT/zF)ln({\[K\]~ex~ + \[Cl\]~in~P~Cl~/P~K~}/{\[K\]~in~ + \[Cl\]~ex~P~Cl~/P~K~}) (Eq. 2)

Measurement of Δψm {#s17}
------------------

All experiments were approved by the Institutional Animal Care and Use Committee of the Korea University College of Medicine (KOREA-2016-0174). Male C57BL/6N mice (6 wk old) were sacrificed for liver mitochondrial isolation. Isolated liver mitochondria were incubated in mitochondrial incubation buffer composed of 250 mM mannitol, 1 mM KH~2~PO~4~, 10 µM EGTA, 2 µM rotenone, and 5 mM Hepes/KOH, pH 7.4, for flow cytometry and spectrophotometric assays. Romo1 was added directly to the isolated liver mitochondria at the indicated concentrations for 5 min, after which the mitochondria were stained with JC-1 (excitation at 488 nm and emission at 525 nm for monomers or 594 nm for aggregates). Isolated mitochondria treated with 90% TFE were used as control. The final TFE concentration was restricted to 0.18%, a percentage at which no significant decrease in Δψm was observed.

Computational modeling {#s18}
----------------------

Romo1 sequences were acquired from publicly available sequences in the NCBI RefSeq database with its name "Romo1" on 06/23/2016; partial sequences were excluded. Each group (animals, plants, fungi, and protists) was extracted as a fasta format file. The human Romo1 sequence was described using the WebLogo 3 server ([@bib10]). The secondary structures were predicted using JPRED ([@bib13]), HMMTOP ([@bib53]), and DISOPRED ([@bib55]). α-Helical wheel illustrations were recreated based on results from the Helical Wheel Projections server (<http://rzlab.ucr.edu/scripts/wheel/wheel.cgi>).

Multiple sequence alignments of Romo1 were obtained using the ClustalW program in MEGA7. To obtain nonredundant sequences of Romo1, we manually deleted the redundant sequences of animals in MEGA7 software using the Find function. If the first species in the Romo1 sequence list was found in other species, these reductant species were deleted. We repeated this protocol to obtain 104 nonredundant sequences. For tertiary structure prediction, the C15--C79 region of the *H. sapiens* Romo1 sequence was used as input for the Robetta and LOMETS servers. The M-ZDOCK server was used to oligomerize Romo1 from tetramers to hexamers without the residue selection option. Structural refinement was performed with the GalaxyRefine-Complex server using symmetric refinement for homooligomers. Oligomers with the lowest MolProbity scores were selected. The pore diameters and pore-lining residues were determined using both PoreWalker and Chexvis. All predicted Romo1 structures were visualized with Jmol software (<http://www.jmol.org/>).

Online supplemental material {#s19}
----------------------------

Fig. S1 shows numerical results of position-specific polarity conservation of Romo1 sequences in 104 animals and 120 fungi. Fig. S2 shows Romo1 oligomerization of chemically synthesized TAMRA-Romo1 or Flag-Romo1 (WT and point mutants) in BN/SDS-PAGE. Fig. S3 shows mitochondrial depolarization induced by Romo1 deletion mutants. Fig. S4 shows the effects of viroporin inhibitors on the channel activity of Romo1. Fig. S5 shows the Romo1 oligomers predicted by experimental data--guided Romo1 structural modeling and their predicted pore diameters.

Supplementary Material
======================

###### Supplemental Materials (PDF)

This study was supported by National Research Foundation of Korea grants funded by the Korean government (NRF-2017M2A2A7A01070813, NRF-2013R1A1A2063171, and NRF-2017R1D1A1B03032322).

The authors declare no competing financial interests.

Author contributions: Y.D. Yoo and G.Y. Lee conceived the project. G.Y. Lee designed all experiments. C.J. Lee and S.W. Hwang guided the patch clamp experiments. G.Y. Lee carried out almost all experiments, and D.-G. You carried out flow cytometric assays. G.Y. Lee, D.-G. You, H.-R. Lee, and Y.D. Yoo analyzed the results. G.Y. Lee wrote the manuscript. Y.D. Yoo and C.J. Lee edited the manuscript. All authors reviewed the manuscript.
